However, serological cytokine analysis demonstrated an increased interleukin-6 (IL-6) level, alongside systemic inflammatory and histopathological features, distinguishing MCD from IgG4RD in this patient. This evidence concerns the gene IL6 and immunoglobulin G4-related sclerosing disease.